Iranian President Mahmoud Ahmadinejad on Monday inaugurated 40 development and industrial projects in Iran's Northern province of Gilan. The projects funded on $700-million of credit were inaugurated simultaneously through video conferencing. The production line of an anti-cancer drug in Sobhan Medicine Company was among the projects inaugurated by President Ahmadinejad today. Last month, Iran inaugurated the production line of another anti-cancer nanodrug under the name Sinadoxosome in the Northern city of Rasht, the provincial capital city of Gilan, and the medicine will soon be introduced to the market. In addition to producing the nanodrug required for the country, this production line makes possible the exportation of the drug to other countries. The drug acquired the necessary certificates from Nanotechnology Committee of the Ministry of Health, Treatment, and Medical Education in November 2011. Sinadoxosome contains nano liposomes that contain doxorubicin anti-cancer medicine. It targets the tumor tissue by using the increase in the permeability mechanism, and it boosts the effect of the medicine but decreases the side effects. The medicine has applications in the treatment of ovarian cancer, breast cancer, and leukemia, and in the treatment of Kaposi's sarcoma (a type of soft tissue cancer).
GMT 17:19 2018 Thursday ,11 January
China factory gate inflation slows to 13-month lowGMT 17:50 2018 Wednesday ,10 January
German industrial output rebounds in NovemberGMT 17:39 2018 Wednesday ,10 January
Samsung tips record Q4 operating profit of more than $14 bnGMT 17:29 2018 Tuesday ,09 January
German industrial orders dip in NovemberGMT 15:36 2018 Thursday ,04 January
China factory activity accelerated in December: CaixinGMT 13:33 2018 Wednesday ,03 January
Turkey inflation rate eases but still stubbornly high in DecemberGMT 16:27 2018 Monday ,01 January
China manufacturing activity slows in DecemberGMT 17:36 2017 Sunday ,31 December
Spain to leave EU's deficit 'sin bin' next year: Rajoy
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor